魯抗醫藥(600789.SH):擬收購中和環保公司60%股權
格隆匯10月8日丨魯抗醫藥(600789.SH)公佈,公司與控股股東華魯控股集團有限公司(“華魯集團”)簽署股權收購意向書,公司擬收購華魯集團持有的山東魯抗中和環保科技有限公司(“中和環保公司”)60%股權(以下簡稱“本次交易”)。
本次交易是為進一步理順管理體制,更好地解決制約公司發展的環保問題。中和環保公司的“三廢治理”是魯抗醫藥生產過程中不可或缺的重要環節。公司目前主要以發酵類抗生素產品為主,生產過程中產生的“三廢”治理均由中和環保公司來承擔。隨着近年來國家環保整治力度的不斷加大,擁有獨立的環保治理能力成為制約企業生存和發展的重要瓶頸。中和環保公司整體併入魯抗醫藥後,可以充分發揮協同效應,有效解決制約企業發展的環保問題。
解決日常關聯交易額度想對較大的問題。目前魯抗醫藥年均日常關聯交易額在1.5億元左右。隨着近年來公司生產規模的不斷擴大,日常關聯交易數額也在持續增加,其中僅與中和環保公司一家公司的年均交易額就在1.3億元左右。通過收購華魯控股所持股權,中和環保公司整體併入魯抗醫藥,該部分關聯交易將不復存在,有利於上市公司規範治理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.